NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$5.71
-0.39 (-6.39%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+656.9% upside
Low Target
$30.63
Average Target
$43.22
High Target
$69.64
Current Price
$5.71
Current
$5.71
$5.71
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Scenario Analysis
Bear Case
$30.63
436.4%
Low target
Base Case
$43.22
+656.9%
Avg target
Bull Case
$69.64
+1,119.6%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$9.75
-41.4% from high
52-Week Low
$2.99
+91.0% from low
Target vs 52W High
$43.22
+343.3% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +15.6% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +7.6% |
| PFE | Hold | 36 | 39% | $33.90 | +20.3% |
| BMY | Hold | 35 | 43% | $174.50 | +185.4% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -37.1% |
| ZTS | Hold | 24 | 50% | $209.87 | +193.1% |